CSFZX
Price
$60.97
Change
+$1.09 (+1.82%)
Updated
Jul 24 closing price
Net Assets
2.31B
PURAX
Price
$23.40
Change
+$0.36 (+1.56%)
Updated
Jul 24 closing price
Net Assets
1.15B
Interact to see
Advertisement

CSFZX vs PURAX

CSFZX vs PURAX Comparison Chart in %
View a ticker or compare two or three
VS
CSFZX vs. PURAX commentary
Jul 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSFZX is a Buy and PURAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSFZX has more cash in the bank: 2.31B vs. PURAX (1.15B). CSFZX pays higher dividends than PURAX: CSFZX (3.24) vs PURAX (2.32). CSFZX was incepted earlier than PURAX: CSFZX (12 years) vs PURAX (28 years). PURAX (1.37) is less costly to investors than CSFZX (0.84). PURAX is a more actively managed with annual turnover of: 94.00 vs. CSFZX (57.00). CSFZX has a lower initial minimum investment than PURAX: CSFZX (0) vs PURAX (1000). PURAX annual gain was more profitable for investors over the last year : 18.28 vs. CSFZX (15.02). CSFZX return over 5 years is better than : 11.32 vs. PURAX (-3.09).
CSFZXPURAXCSFZX / PURAX
Total Expense Ratio0.841.3761%
Annual Report Gross Expense Ratio0.841.3761%
Fund Existence12 years28 years-
Gain YTD13.39315.90084%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.31B1.15B201%
Annual Yield % from dividends3.242.32140%
Returns for 1 year15.0218.2882%
Returns for 3 years30.4134.3189%
Returns for 5 years11.32-3.09-366%
Returns for 10 years54.3215.88342%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSVZX47.310.32
+0.68%
Columbia Select Large Cap Value Inst
SMDIX22.260.06
+0.27%
Hartford Schroders US MidCap Opps I
RPTIX98.95-0.16
-0.16%
T. Rowe Price Mid-Cap Growth I
JMNSX15.25-0.03
-0.20%
JPMorgan Research Market Neutral I
MELIX17.49-0.32
-1.80%
Morgan Stanley Inst EMkts Ldrs I